FeesSafety
Pluang+

WhiteHorse Finance reports Q3 2026 results, declares $0.25/share dividend for Q4, and lowers incentive fee.

Company Fundamentals
09 Nov 2026, 15:00 WIB
PRNewsWire
View Source
Bullish
WhiteHorse Finance reports Q3 2026 results, declares $0.25/share dividend for Q4, and lowers incentive fee.

WhiteHorse Finance announced its Q3 2026 financial results, showing a slight increase in net asset value per share and stable core net investment income. The company declared a $0.25 per share dividend for Q4 2026, payable in January 2027. It also voluntarily reduced its incentive fee from 20% to 17.5% for the next fiscal quarter to enhance shareholder value. The firm continues to focus on managing its portfolio prudently, investing mainly in first lien loans, and redeploying capital from equitized positions into income-producing assets.

WhiteHorse Finance's Q3 2026 earnings and dividend announcement provide context for financial sector activity on Pluang. For readers following Financials, here is Pluang's market snapshot as of Nov 09, 2026 19:13 WIB: out of 142 priced Financials-sector US stocks, 98 rose and 18 fell today. Banco Santander SA (SAN) gained 4.05% to USD 12.21 with a typical hold time of 56 days, contrasting with Hyperliquid Strategies Inc (PURR) which dropped 3.69% to USD 8.49 and a much shorter hold time of 6 days. Deutsche Bank AG (DB) also rose 3.62% to USD 36.10, with the longest hold time among these at 82 days.

More News

Microsoft to retire UWP Map Control by Nov 2026; OnTerra offers ready replacement using Azure Maps.

Microsoft to retire UWP Map Control by Nov 2026; OnTerra offers ready replacement using Azure Maps.

Microsoft will retire the backend services for its UWP Map Control and Windows Maps APIs on November 30, 2026, ending map functionality in many Windows desktop and tablet applications. OnTerra Systems, a Microsoft partner, has developed an off-the-sh...

Market News
Neutral
1 hour ago
New combo therapy shows promise in tough metastatic breast cancer cases with high response rates

New combo therapy shows promise in tough metastatic breast cancer cases with high response rates

Marengo Therapeutics presented interim Phase 2 results from the STARt-002 trial combining invikafusp alfa, a selective T-cell agonist, with sacituzumab govitecan in metastatic triple-negative and HR-positive/HER2-negative breast cancer. The trial sho...

Company Fundamentals
Bullish
2 hours ago
Deadlines set for lead plaintiff appointments in class action lawsuits against Ensign, Netcapital, and Webull.

Deadlines set for lead plaintiff appointments in class action lawsuits against Ensign, Netcapital, and Webull.

Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against The Ensign Group, Netcapital Inc., and Webull Corporation. These lawsuits allege misleading statements and failure to di...

Bearish
2 hours ago
Octave launches Attune Facilities, an AI-driven tool for managing complex multi-site operations efficiently.

Octave launches Attune Facilities, an AI-driven tool for managing complex multi-site operations efficiently.

Octave Intelligence plc has introduced Octave Attune Facilities, a cloud-based software solution designed to help organizations manage multiple sites with AI-powered tools. This platform integrates building, space, maintenance, and operational data t...

Market News
Bullish
2 hours ago
ITT Inc. price target raised to $259 after strong Q3 with 44% revenue growth and 20% earnings rise.

ITT Inc. price target raised to $259 after strong Q3 with 44% revenue growth and 20% earnings rise.

ITT Inc. reported a strong third quarter with revenue up 44% to over $1.40 billion and adjusted earnings rising 20% to $2.26 per share, driven by the SPX FLOW acquisition and 8% organic growth. Orders surged 58%, supported by aerospace, defense, and ...

Analyst Insights
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App